BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29328502)

  • 1. Hepatocellular carcinoma-related cyclin D1 is selectively regulated by autophagy degradation system.
    Wu SY; Lan SH; Wu SR; Chiu YC; Lin XZ; Su IJ; Tsai TF; Yen CJ; Lu TH; Liang FW; Li CY; Su HJ; Su CL; Liu HS
    Hepatology; 2018 Jul; 68(1):141-154. PubMed ID: 29328502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradative autophagy selectively regulates CCND1 (cyclin D1) and MIR224, two oncogenic factors involved in hepatocellular carcinoma tumorigenesis.
    Wu SY; Lan SH; Liu HS
    Autophagy; 2019 Apr; 15(4):729-730. PubMed ID: 30646811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitination of UVRAG by SMURF1 promotes autophagosome maturation and inhibits hepatocellular carcinoma growth.
    Feng X; Jia Y; Zhang Y; Ma F; Zhu Y; Hong X; Zhou Q; He R; Zhang H; Jin J; Piao D; Huang H; Li Q; Qiu X; Zhang Z
    Autophagy; 2019 Jul; 15(7):1130-1149. PubMed ID: 30686098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination of lonafarnib and sorafenib induces cyclin D1 degradation via ATG3-mediated autophagic flux in hepatocellular carcinoma cells.
    Wang J; Wei H; Huang Y; Chen D; Zeng G; Lian Y; Huang Y
    Aging (Albany NY); 2019 Aug; 11(15):5769-5785. PubMed ID: 31409760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wogonin inhibits cell cycle progression by activating the glycogen synthase kinase-3 beta in hepatocellular carcinoma.
    Hong M; Almutairi MM; Li S; Li J
    Phytomedicine; 2020 Mar; 68():153174. PubMed ID: 31991293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic investigation based on microRNA-mediated gene regulatory network reveals that dysregulation of microRNA-19a/Cyclin D1 axis confers an oncogenic potential and a worse prognosis in human hepatocellular carcinoma.
    Zhang Y; Guo X; Li Z; Li B; Li Z; Li R; Guo Q; Xiong L; Yu L; Zhao J; Lin N
    RNA Biol; 2015; 12(6):643-57. PubMed ID: 25985117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy suppresses tumorigenesis of hepatitis B virus-associated hepatocellular carcinoma through degradation of microRNA-224.
    Lan SH; Wu SY; Zuchini R; Lin XZ; Su IJ; Tsai TF; Lin YJ; Wu CT; Liu HS
    Hepatology; 2014 Feb; 59(2):505-17. PubMed ID: 23913306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of zinc finger protein 384 (ZNF 384), a poor prognostic predictor, promotes cell growth by upregulating the expression of Cyclin D1 in Hepatocellular carcinoma.
    He L; Fan X; Li Y; Chen M; Cui B; Chen G; Dai Y; Zhou D; Hu X; Lin H
    Cell Death Dis; 2019 Jun; 10(6):444. PubMed ID: 31168049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of optineurin impairs the progression of hepatocellular carcinoma through regulating mitophagy.
    Inokuchi S; Yoshizumi T; Toshima T; Itoh S; Yugawa K; Harada N; Mori H; Fukuhara T; Matsuura Y; Mori M
    Cancer Med; 2021 Mar; 10(5):1501-1514. PubMed ID: 33600074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of eEF1A1 regulates G1-phase progression to promote HCC proliferation through the STAT1-cyclin D1 pathway.
    Huang J; Zheng C; Shao J; Chen L; Liu X; Shao J
    Biochem Biophys Res Commun; 2017 Dec; 494(3-4):542-549. PubMed ID: 29079187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma.
    Shimizu S; Takehara T; Hikita H; Kodama T; Tsunematsu H; Miyagi T; Hosui A; Ishida H; Tatsumi T; Kanto T; Hiramatsu N; Fujita N; Yoshimori T; Hayashi N
    Int J Cancer; 2012 Aug; 131(3):548-57. PubMed ID: 21858812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA Binding Protein HuR Promotes Autophagosome Formation by Regulating Expression of Autophagy-Related Proteins 5, 12, and 16 in Human Hepatocellular Carcinoma Cells.
    Ji E; Kim C; Kang H; Ahn S; Jung M; Hong Y; Tak H; Lee S; Kim W; Lee EK
    Mol Cell Biol; 2019 Mar; 39(6):. PubMed ID: 30602494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of SYF2 correlates with enhanced cell growth and poor prognosis in human hepatocellular carcinoma.
    Zhang S; Shi W; Chen Y; Xu Z; Zhu J; Zhang T; Huang W; Ni R; Lu C; Zhang X
    Mol Cell Biochem; 2015 Dec; 410(1-2):1-9. PubMed ID: 26260052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smad inhibitor induces CSC differentiation for effective chemosensitization in cyclin D1- and TGF-β/Smad-regulated liver cancer stem cell-like cells.
    Xia W; Lo CM; Poon RYC; Cheung TT; Chan ACY; Chen L; Yang S; Tsao GSW; Wang XQ
    Oncotarget; 2017 Jun; 8(24):38811-38824. PubMed ID: 28415588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription Factor MafB Promotes Hepatocellular Carcinoma Cell Proliferation through Up-Regulation of Cyclin D1.
    Yu H; Jiang HL; Xu D; Jin JZ; Zhao ZM; Ma YD; Liang J
    Cell Physiol Biochem; 2016; 39(2):700-8. PubMed ID: 27448450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
    Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of deregulated CDK4 and Cyclin D1 expression in patients with human hepatocellular carcinoma.
    Lu JW; Lin YM; Chang JG; Yeh KT; Chen RM; Tsai JJ; Su WW; Hu RM
    Med Oncol; 2013 Mar; 30(1):379. PubMed ID: 23292829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.
    Hu C; Liu D; Zhang Y; Lou G; Huang G; Chen B; Shen X; Gao M; Gong W; Zhou P; Dai S; Zeng Y; He F
    Oncogene; 2014 May; 33(22):2888-97. PubMed ID: 23812424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of the p53-inducible antiproliferative gene BTG2 in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins.
    Zhang Z; Chen C; Wang G; Yang Z; San J; Zheng J; Li Q; Luo X; Hu Q; Li Z; Wang D
    Cell Biochem Biophys; 2011 Sep; 61(1):83-91. PubMed ID: 21327578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Q6, a novel hypoxia-targeted drug, regulates hypoxia-inducible factor signaling via an autophagy-dependent mechanism in hepatocellular carcinoma.
    Liu XW; Cai TY; Zhu H; Cao J; Su Y; Hu YZ; He QJ; Yang B
    Autophagy; 2014 Jan; 10(1):111-22. PubMed ID: 24220190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.